Journal article
Inhibition of DNA-dependent protein kinase catalytic subunit boosts rAAV transduction of polarized human airway epithelium
Molecular therapy. Methods & clinical development, Vol.31, 101115
12/2023
DOI: 10.1016/j.omtm.2023.101115
PMCID: PMC10568418
PMID: 37841417
Abstract
Adeno-associated virus (AAV)2.5T was selected from the directed evolution of AAV capsid library in human airway epithelia. This study found that recombinant (r)AAV2.5T transduction of well-differentiated primary human airway epithelia induced a DNA damage response (DDR), characterized by the phosphorylation of replication protein A32 (RPA32), histone variant H2AX (H2A histone family member X), and all three phosphatidylinositol 3-kinase-related kinases (PIKKs): Ataxia-telangiectasia mutated kinase (ATM), Ataxia telangiectasia and Rad3-related kinase (ATR), and DNA-dependent protein kinase catalytic subunit (DNA-PKcs). While suppressing the expression of ATR by a specific pharmacological inhibitor or targeted gene silencing inhibited rAAV2.5T transduction, DNA-PKcs inhibition or targeted gene silencing significantly increased rAAV2.5T transgene expression. Notably, DNA-PKcs inhibitors worked as a “booster” to further increase rAAV2.5T transgene expression after treatment with doxorubicin and did not compromise epithelial integrity. Thus, our study provides evidence that DDR is associated with rAAV transduction in well-differentiated human airway epithelia, and DNA-PKcs inhibition has the potential to boost rAAV transduction. These findings highlight that the application of DDR inhibition-associated pharmacological interventions has the potential to increase rAAV transduction and thus to reduce the required vector dose.
[Display omitted]
Details
- Title: Subtitle
- Inhibition of DNA-dependent protein kinase catalytic subunit boosts rAAV transduction of polarized human airway epithelium
- Creators
- Kang Ning - University of Kansas Medical CenterXiujuan Zhang - University of Kansas Medical CenterZehua Feng - University of IowaSiyuan Hao - University of Kansas Medical CenterCagla Aksu Kuz - University of Kansas Medical CenterFang Cheng - University of Kansas Medical CenterSoo Yuen Park - Department of Anatomy and Cell Biology, University of Iowa, Iowa City, IA 52242, USAShane McFarlin - University of Kansas Medical CenterJohn F. Engelhardt - University of IowaZiying Yan - University of IowaJianming Qiu - University of Kansas Medical Center
- Resource Type
- Journal article
- Publication Details
- Molecular therapy. Methods & clinical development, Vol.31, 101115
- DOI
- 10.1016/j.omtm.2023.101115
- PMID
- 37841417
- PMCID
- PMC10568418
- NLM abbreviation
- Mol Ther Methods Clin Dev
- ISSN
- 2329-0501
- eISSN
- 2329-0501
- Publisher
- Elsevier Inc
- Grant note
- DOI: 10.13039/100000060, name: NIAID, award: AI150877, AI156448; DOI: 10.13039/100000062, name: NIDDK, award: DK054759; DOI: 10.13039/100008893, name: University of Iowa; DOI: 10.13039/100000002, name: National Institutes of Health, award: S10 OD 023625
- Language
- English
- Electronic publication date
- 09/2023
- Date published
- 12/2023
- Academic Unit
- Anatomy and Cell Biology; Radiation Oncology; Internal Medicine
- Record Identifier
- 9984472656802771
Metrics
9 Record Views